Improving Outcomes for Noncommunicable Diseases in Low- and Middle-Income Countries
Subramanian, S., Hoover, S., & Edwards, P. V. (2016). Improving Outcomes for Noncommunicable Diseases in Low- and Middle-Income Countries. In Improving outcomes for noncommunicable diseases in low- and middle-income countries (pp. 1-10). RTI Press. https://doi.org/10.3768/rtipress.2016.bk.0017.1608
Noncommunicable diseases (NCDs) are the main cause of death worldwide. In addition, the incidence, prevalence, and death rates from NCDs are expected to increase in the future. No single discipline can address the issues of prevention, early detection, access to care, and appropriate treatment that are needed to improve outcomes for NCDs; this growing need will require transdisciplinary collaborations. Improving outcomes in NCDs is clearly a difficult endeavor that will require significant efforts. However, previous research and program implementation indicate that improving outcomes for NCDs is an achievable goal. Given the tremendous impact of NCDs on morbidity, mortality, and costs worldwide, there is little doubt that efforts to improve NDC outcomes are much needed. Recognizing the importance of new strategies and interventions addressing NCDS globally, RTI funded the projects described here to assess how the institute’s range of expertise could be focused on the reduction of NCDs. The projects described in this book focus on the risk factors or treatment (or both) of one or more of the four NCDs that are responsible for the greatest impact on morbidity and mortality: cardiovascular disease, cancer, diabetes, and chronic respiratory diseases. The pilot projects were carried out in low- and middle-income countries, which are disproportionately affected by NCDs. The lessons learned from these initial pilot projects have great potential to be increased in their scale and reduce the devastating impact of noncommunicable diseases.
March 2017: This version contains the following updates to Chapter 4 since the original publication: a copyright notice for the Morisky Medication Adherence Scale has been added to page 67 and to Tables 4.1 and 4.3, and two references have been added, 28 and 29, which caused some renumbering of nearby references. In addition, the words “Mean at” have been removed from the Baseline and 3 Months columns in Table 4.3.